Revue française des affaires sociales 2007/3

Medication

Revue française des affaires sociales
Issue 3-4, September 2007

Pages: 356
Publisher: La Doc. française

Medication

Page 7 to 23

Presentation of the Issue
Regulation, Assessment, and Social Life of Medication
Daniel Benamouzig, Valérie Paris

Page 25 to 51

Page 53 to 72

Page 73 to 86

Is It Possible to Improve Both the Quality and Efficiency of Prescription Drugs?
Lessons from French Health Insurance
Dominique Polton, Philippe Ricordeau, Hubert Allemand

Page 87 to 98

Page 99 to 121

The Definition of Generic Drugs: Therapeutic and Economic Issues
The Example of the Proton-Pump Inhibitor Market in France
Étienne Nouguez

Page 123 to 151

Error, Accident, or Iatrogenic Risk?
The Regulation of Adverse Side-Effects of Medication following the Stalinon and Distilbène Incidents
Christian Bonah, Jean-Paul Gaudillière

Page 153 to 170

Page 171 to 191

What Is the Role of Patient Associations in Medicinal Innovation?
The Case of Rare Illnesses
Sébastien Dalgalarrondo

Page 193 to 209

Page 211 to 231

Small Businesses, Big Dependency
Pharmacies: Between Government and Industry Powers
Pierre Fournier, Cédric Lomba

Page 233 to 256

Page 257 to 277

Page 279 to 308

Page 309 to 318

Decision Transparency in Medication Reimbursement in Poland
Presentation of the Institutional Similarities between France and Poland (October 2006–February 2008)
Laurence Moureau, Philippe Sauvage

Page 319 to 341

Considering Therapeutic Innovation in Pricing Policies and Medication Reimbursement
An International Approach
Catherine Sermet

Current Research

Page 343 to 352

Reviews

Page 351 to 364

Reviews

This thematic journal covering the fields of health and society is under the editorial responsibility of the Direction de la recherche, des études, de l’évaluation, et des statistiques or DREES (a directorate of the central administration of the health and social Ministries). Read more...

Uploaded on Cairn-int.info on 30/11/-0001